Search for: "Hyman Phelps McNamara" Results 21 - 40 of 404
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Dec 2010, 11:14 pm by FDABlog HPM
Hyman, Phelps & McNamara’s Paul Hyman and Ricardo Carvajal recently published an article in Food Chemical News on the cost of inadequate substantiation of health-related claims made in the labeling and advertising of foods.  [read post]
2 Feb 2011, 3:31 pm by FDABlog HPM
In his recent article appearing in FDLI Update, Hyman, Phelps & McNamara, P.C. [read post]
3 Aug 2011, 2:40 pm by FDABlog HPM
In his recent article appearing in FDLI Update, Hyman, Phelps & McNamara, P.C.’s Douglas B. [read post]
22 Nov 2011, 7:51 pm by FDABlog HPM
In his recent article appearing in FDLI Update, Hyman, Phelps & McNamara, P.C. [read post]
16 May 2016, 10:27 am by FDABlog HPM
The FDA Law Blog is pleased to announce the release of the FDA Deskbook, prepared by the attorneys at Hyman, Phelps & McNamara, P.C., the same authors who provide the expertise and analysis contained in this blog. [read post]
10 Nov 2014, 8:28 pm by FDABlog HPM
Hyman, Phelps & McNamara, P.C. has once again been ranked as a “Tier 1” law firm in the area of “FDA Law” (both nationally and in Washington, D.C.) by the folks over at U.S. [read post]
4 Nov 2012, 11:35 pm by FDABlog HPM
Frank Sasinowki, Director at Hyman, Phelps & McNamara, P.C. and board member of the National Organization for Rare Disorders ("NORD"), is giving the keynote address for the Campaign Urging Research for Eosinophilic Disease’s ("CURED’s") first research symposium on eosinophilic gastrointestinal disorders ("EGID").  [read post]
4 Nov 2012, 11:35 pm by FDABlog HPM
Frank Sasinowki, Director at Hyman, Phelps & McNamara, P.C. and board member of the National Organization for Rare Disorders ("NORD"), is giving the keynote address for the Campaign Urging Research for Eosinophilic Disease’s ("CURED’s") first research symposium on eosinophilic gastrointestinal disorders ("EGID").  [read post]
8 Nov 2011, 6:08 am by FDABlog HPM
For the second year in a row, Hyman, Phelps & McNamara, P.C. has been ranked as a “Tier 1” law firm in the area of FDA Law (both nationally and in Washington DC) by the folks over at U.S. [read post]
8 Feb 2013, 2:32 pm by FDABlog HPM
On January 31, 2013, Hyman, Phelps & McNamara, P.C. presented a webinar addressing the real-world implications from the Second Circuit decision in United States v. [read post]
4 Dec 2012, 7:21 pm by FDABlog HPM
Hyman, Phelps & McNamara, P.C., the nation’s largest boutique food and drug regulatory law firm, seeks an associate with three to six years experience in medical device law and regulation to assist with a growing practice. [read post]
20 Sep 2011, 11:10 am by FDABlog HPM
Hyman, Phelps & McNamara, P.C.’s Ricardo Carvajal will be presenting at the following upcoming conferences on food law and policy. [read post]